(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
---|---|---|---|---|---|---|---|
Turnover | 41.67%515.12M | 81.84%1.01B | 113.62%363.59M | 10.20%553.62M | --170.2M | 37.59%502.37M | --365.12M |
Operating income | 41.67%515.12M | 81.84%1.01B | 113.62%363.59M | 10.20%553.62M | 170.2M | 37.59%502.37M | 365.12M |
Cost of sales | -37.88%-233.69M | -115.29%-471.43M | -96.39%-169.48M | -39.59%-218.98M | ---86.3M | -26.53%-156.88M | ---123.98M |
Operating expenses | -37.88%-233.69M | -115.29%-471.43M | -96.39%-169.48M | -39.59%-218.98M | -86.3M | -26.53%-156.88M | -123.98M |
Gross profit | 44.98%281.42M | 59.95%535.27M | 131.35%194.11M | -3.14%334.64M | 83.9M | 43.28%345.49M | 241.14M |
Selling expenses | -49.01%-141.95M | -43.09%-239.28M | -25.39%-95.26M | 11.73%-167.23M | ---75.97M | -62.31%-189.46M | ---116.73M |
Administrative expenses | -12.86%-36.32M | -103.65%-54.54M | -186.26%-32.18M | 5.95%-26.78M | ---11.24M | -9.65%-28.47M | ---25.97M |
Research and development expenses | -37.27%-37.48M | -110.04%-63.25M | -114.41%-27.31M | 48.97%-30.11M | ---12.74M | 12.93%-59.01M | ---67.78M |
Revaluation surplus | -5,951.04%-1.9B | 87.42%-24.09M | 142.22%32.42M | -1.08%-191.47M | ---76.81M | -34.93%-189.42M | ---140.38M |
-Changes in the fair value of financial assets | --2.27M | 87.42%-24.09M | ---- | -1.08%-191.47M | ---- | ---189.42M | ---- |
-Changes in the fair value of other assets | -5,958.05%-1.9B | ---- | 142.22%32.42M | ---- | ---76.81M | ---- | ---140.38M |
Impairment and provision | -6,291.30%-5.88M | 100.77%197K | 98.55%-92K | -58.89%-25.7M | ---6.34M | -435.66%-16.18M | ---3.02M |
-Other impairment is provision | -6,291.30%-5.88M | 100.77%197K | 98.55%-92K | -58.89%-25.7M | ---6.34M | -435.66%-16.18M | ---3.02M |
Special items of operating profit | 872.37%4.26M | -13.20%4.14M | -80.60%438K | -20.07%4.77M | --2.26M | 167.91%5.97M | --2.23M |
Operating profit | -2,641.26%-1.83B | 255.52%158.45M | 174.42%72.13M | 22.28%-101.88M | -96.93M | -18.62%-131.08M | -110.51M |
Financing cost | -384.02%-4M | 50.96%-1.61M | 60.31%-826K | 41.31%-3.29M | ---2.08M | -48.30%-5.6M | ---3.77M |
Earning before tax | -2,676.30%-1.84B | 249.13%156.84M | 172.02%71.31M | 23.05%-105.17M | -99.01M | -19.60%-136.68M | -114.28M |
Tax | -54.83%-9.16M | -84.89%-20.13M | -224.33%-5.92M | -288.93%-10.89M | --4.76M | -232.39%-2.8M | --2.12M |
After-tax profit from continuing operations | -2,923.44%-1.85B | 217.79%136.7M | 169.38%65.39M | 16.79%-116.06M | -94.25M | -24.35%-139.48M | -112.16M |
Earning after tax | -2,923.44%-1.85B | 217.79%136.7M | 169.38%65.39M | 16.79%-116.06M | -94.25M | -24.35%-139.48M | -112.16M |
Minority profit | 111.63%1.62M | 18,100.00%5.76M | 4,881.25%765K | -146.15%-32K | ---16K | ---13K | ---- |
Profit attributable to shareholders | -2,959.36%-1.85B | 212.86%130.94M | 168.58%64.63M | 16.81%-116.03M | -94.24M | -24.34%-139.47M | -112.16M |
Basic earnings per share | -2,311.29%-13.71 | 212.61%1.25 | 168.89%0.62 | 17.16%-1.11 | -0.9 | -25.23%-1.34 | -1.07 |
Diluted earnings per share | -17,237.50%-13.71 | 150.45%0.56 | 108.89%0.08 | 17.16%-1.11 | -0.9 | -25.23%-1.34 | -1.07 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data